Loading organizations...
Loading organizations...
Medical device company specializing in diabetes management systems.
CellNovo has raised $77.0M across 3 funding rounds.
CellNovo has raised $77.0M in total across 3 funding rounds.
CellNovo has raised $77.0M in total across 3 funding rounds.
CellNovo's investors include Ambroise Fayolle, Advent Venture Partners, Auriga Partners, Credit Agricole Private Equity, Forbion, HealthCare Ventures, NBGI Ventures, Nesta.
CellNovo has raised $77.0M across 3 funding rounds. Most recently, it raised $22.8M Debt in July 2017.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jul 10, 2017 | $22.8M Debt | Ambroise Fayolle | |
| Oct 20, 2016 | $5.9M Other Equity | ||
| Feb 4, 2011 | $48.3M Series B | Advent Venture Partners, Auriga Partners, Credit Agricole Private Equity, Forbion, HealthCare Ventures, NBGI Ventures, Nesta |